Daily SPAC Update – December 19, 2024

by | Dec 19, 2024

FTAC Emerald and Kairous Acquisition Delistings as Shareholders Approve Extensions. Bowen Acquisition Deal Vote Set. GSRT, TAVI, FACT Set to Trade Separately.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC VOTE RESULTS
KACL – KAIROUS ACQUISITION CORP LTD * Extend to Jun 16, 2025 * 518,968 redeemed
FLD – FTAC EMERALD ACQUISITION CORP * Extend to Dec 20, 2025 * 112,068 redeemed * trust $11.02

SPAC DEAL & EXTENSION VOTES SET
BOWN – Bowen Acquisition Corp * DEAL VOTE SET: Jan 13, 2025 * trust $10.94
AOGO – Arogo Capital Acquisition Corp * EXTENSION VOTE SET: Dec 28, 2024 * trust $11.53

SEPARATE WARRANTS/RIGHTS
TAVI on Dec 20
FACT on Dec 20
GSRT on Dec 19

OTHER SPAC NEWS
FLD – FTAC EMERALD ACQUISITION CORP * Delisting
KACL – KAIROUS ACQUISITION CORP LTD * Delisting
OAKU – OAK WOODS ACQUISITION CORP * Merger Agreement Amendment

YESTERDAY’S TOP SPAC GAINERS
5.83% ~ $ 11.99 | GLST – Global Star Acquisition Inc. (Announced)
1.49% ~ $ 10.53 | CCIX – Churchill Capital Corp IX (Pre-Deal)
1.19% ~ $ 10.59 | CEP – Cantor Equity Partners Inc (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-24.40% ~ $ 5.08 | MARX – Mars Acquisition Corp. (Announced)
-11.88% ~ $ 7.05 | BOCN – Blue Ocean Acquisition Corp (Announced)
-7.92% ~ $ 10.81 | GLLI – Globalink Investment Inc. (Announced)
-6.35% ~ $ 2.95 | ROCL – Roth CH Acquisition V Co. (Announced)
-6.30% ~ $ 10.86 | HAIA – Healthcare AI Acquisition Corp. (Announced)

LATEST SPAC IPO PERFORMANCE
Dec 12 | $ 10.02 | MLAC – Mountain Lake Acquisition Corp.
Dec 12 | $ 9.95 | DRDB – Roman DBDR Acquisition Corp. II
Dec 10 | $ 10.02 | JACS – Jackson Acquisition Co II
Dec 04 | $ 10.02 | SPHA – Shepherd Ave Capital Acquisition Corp
Dec 04 | $ 10.00 | TAVI – Tavia Acquisition Corp.
Nov 26 | $ 9.97 | FACT – FACT II Acquisition Corp.
Nov 20 | $ 9.93 | DYNX – Dynamix Corporation
Nov 20 | $ 9.99 | NOEM – CO2 Energy Transition Corp.

 

Recent Analysis

Daily SPAC Update – January 16, 2025

LATG DeSPACs to Femco Steel Technology (KBSX). Plum Acquisition III Extension Vote. RRAC and EVGR Extension Votes Set. NOEM Separate Trading on Jan 16. 

Daily SPAC Update – January 15, 2025

$150M Plum Acquisition IV and $50M Ribbon Acquisition SPAC IPOs. Aimfinity (AIMAU) and Quetta (QETA) Extensions Approved. Bowen (BOWN) + Qianzhi BioTech Deal Approved. 

Daily SPAC Update – January 14, 2025

Cohen Circle (CCIR) LOI with Ukranian Firm. BRKH DeSPACs to Blaize (BZAI). PPYA Extension Vote. Aimfinity Extends to Oct 2025. Bowen Acquisition (BOWN) Forward Purchase Agreement. 

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.